The TGA have published new guidance on the Data Protection scheme for assessed listed medicines, which was introduced into the Therapeutic Goods Act 1989 in February 2021. The guidance outlines in detail the operation of the Scheme and requirements and expectations for the sector to utilise the Scheme.

Please read today's full Member Alert for more information and details, including on clinical trial and eligibility requirements of the Scheme.